NuCana (NCNA) Exchange Rate Effect (2017 - 2025)
NuCana's (NCNA) quarterly Exchange Rate Effect came in at $14631.8 in Q4 2025, down 98.24% year-on-year from $829142.2 in Q4 2024, and down 95.2% quarter-over-quarter from $304955.8 in Q3 2025.
NuCana (NCNA) Exchange Rate Effect (2017 - 2025) Analysis & Trends
NuCana has disclosed Exchange Rate Effect across 9 years of filings, most recently posting $14631.8 for Q4 2025.
- Exchange Rate Effect for Q4 2025 came in at $14631.8, down 98.24% year-over-year; the trailing twelve-month figure through Dec 2025 was $656295.1 (up 37.1% YoY), and the FY2025 annual result was -$258428.0, down 153.34% from the prior year.
- Exchange Rate Effect came in at $14631.8 for Q4 2025 at NuCana, down from $304955.8 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $3.9 million in Q2 2022 to a low of -$914224.5 in Q1 2021.
- The 5-year median for Exchange Rate Effect is $16782.6 (2024), against an average of $338196.2.
- Across the five-year window, Exchange Rate Effect slumped 218.96% in 2021 and soared 3081.93% in 2022, its largest moves.
- NuCana's Exchange Rate Effect stood at -$186025.5 in 2021, then jumped by 2183.68% to $3.9 million in 2022, then plunged by 116.36% to -$634228.6 in 2023, then soared by 230.73% to $829142.2 in 2024, then sank by 98.24% to $14631.8 in 2025.
- The last three Exchange Rate Effect figures came in at $14631.8 (Q4 2025), $304955.8 (Q3 2025), and $829142.2 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 8.68 Mn |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | 14,631.83 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14,631.83 |
| Dec 31, 2025 | 14,631.83 |
| Sep 30, 2025 | 304,955.85 |
| Sep 30, 2025 | 304,955.85 |
| Dec 31, 2024 | 829,142.19 |
| Dec 31, 2024 | 829,142.19 |
| Sep 30, 2024 | -492,434.76 |
| Sep 30, 2024 | -492,434.76 |
| Jun 30, 2024 | 18,933.31 |
| Jun 30, 2024 | 18,933.31 |
| Mar 31, 2024 | 123,046.26 |
| Mar 31, 2024 | 123,046.26 |
| Dec 31, 2023 | -634,228.61 |
| Dec 31, 2023 | -634,228.61 |
| Sep 30, 2023 | 787,877.94 |
| Sep 30, 2023 | 787,877.94 |
| Jun 30, 2023 | -620,676.12 |
| Jun 30, 2023 | -620,676.12 |
| Mar 31, 2023 | -848,425.64 |
| Mar 31, 2023 | -848,425.64 |